TSBP1-AS1
|
|
TSBP1 and BTNL2 antisense RNA 1
|
|
39
|
0.638 |
0.692 |
|
0.100 |
None
|
1.000 |
6
|
221
|
2007 |
2014 |
HLA-DRB9
|
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
21
|
0.682 |
0.654 |
|
0.100 |
None
|
1.000 |
5
|
21
|
2007 |
2019 |
MSH5-SAPCD1
|
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
8
|
0.760 |
0.423 |
|
0.100 |
None
|
1.000 |
3
|
10
|
2007 |
2011 |
ATP6V1G2-DDX39B
|
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
12
|
0.769 |
0.423 |
|
0.100 |
None
|
1.000 |
3
|
8
|
2007 |
2011 |
PPT2-EGFL8
|
|
PPT2-EGFL8 readthrough (NMD candidate)
|
|
9
|
0.792 |
0.462 |
|
0.100 |
None
|
1.000 |
3
|
6
|
2007 |
2011 |
Entrez Id: |
102060414 |
Gene Symbol: |
C2-AS1 |
C2-AS1
|
|
C2 antisense RNA 1
|
|
3
|
0.821 |
0.192 |
|
0.100 |
None
|
1.000 |
3
|
5
|
2007 |
2011 |
EHMT2-AS1
|
|
EHMT2 and SLC44A4 antisense RNA 1
|
|
7
|
0.780 |
0.462 |
|
0.100 |
None
|
1.000 |
3
|
4
|
2007 |
2011 |
Entrez Id: |
253018 |
Gene Symbol: |
HCG27 |
HCG27
|
|
HLA complex group 27
|
|
6
|
0.805 |
0.346 |
2.3E-02 |
0.100 |
None
|
1.000 |
3
|
4
|
2007 |
2011 |
Entrez Id: |
267015 |
Gene Symbol: |
HLA-S |
HLA-S
|
|
major histocompatibility complex, class I, S (pseudogene)
|
|
2
|
0.931 |
0.192 |
|
0.100 |
None
|
1.000 |
3
|
1
|
2007 |
2011 |
COL11A2P1
|
|
collagen type XI alpha 2 pseudogene 1
|
|
6
|
0.805 |
0.462 |
|
0.100 |
None
|
1.000 |
3
|
5
|
2007 |
2011 |
HLA-DPA2
|
|
major histocompatibility complex, class II, DP alpha 2 (pseudogene)
|
|
6
|
0.780 |
0.538 |
|
0.100 |
None
|
1.000 |
3
|
7
|
2007 |
2011 |
Entrez Id: |
100129772 |
Gene Symbol: |
TMPOP1 |
TMPOP1
|
|
thymopoietin pseudogene 1
|
|
2
|
1.000 |
0.115 |
|
0.100 |
None
|
1.000 |
2
|
1
|
2007 |
2009 |
Entrez Id: |
10255 |
Gene Symbol: |
HCG9 |
HCG9
|
|
HLA complex group 9
|
|
9
|
0.700 |
0.500 |
|
0.100 |
None
|
1.000 |
2
|
2
|
2007 |
2009 |
LINC02571
|
|
long intergenic non-protein coding RNA 2571
|
|
18
|
0.743 |
0.500 |
|
0.100 |
None
|
1.000 |
2
|
9
|
2007 |
2011 |
Entrez Id: |
145837 |
Gene Symbol: |
DRAIC |
DRAIC
|
|
downregulated RNA in cancer, inhibitor of cell invasion and migration
|
|
6
|
0.736 |
0.423 |
|
0.100 |
None
|
1.000 |
2
|
1
|
2012 |
2019 |
LINC02649
|
|
long intergenic non-protein coding RNA 2649
|
|
6
|
0.792 |
0.308 |
|
0.100 |
None
|
1.000 |
2
|
2
|
2012 |
2019 |
LINC00243
|
|
long intergenic non-protein coding RNA 243
|
|
15
|
0.729 |
0.423 |
|
0.100 |
None
|
1.000 |
2
|
6
|
2007 |
2009 |
Entrez Id: |
414771 |
Gene Symbol: |
DDR1-DT |
DDR1-DT
|
|
DDR1 divergent transcript
|
|
2
|
0.931 |
0.115 |
|
0.100 |
None
|
1.000 |
2
|
1
|
2007 |
2009 |
Entrez Id: |
414777 |
Gene Symbol: |
HCG18 |
HCG18
|
|
HLA complex group 18
|
|
12
|
0.722 |
0.538 |
|
0.100 |
None
|
1.000 |
2
|
4
|
2007 |
2009 |
Entrez Id: |
414778 |
Gene Symbol: |
HCG17 |
HCG17
|
|
HLA complex group 17
|
|
12
|
0.769 |
0.346 |
|
0.100 |
None
|
1.000 |
2
|
6
|
2007 |
2009 |
ZNRD1ASP
|
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
12
|
0.691 |
0.538 |
|
0.100 |
None
|
1.000 |
2
|
2
|
2007 |
2009 |
ZDHHC20P2
|
|
zinc finger DHHC-type containing 20 pseudogene 2
|
|
1
|
0.890 |
0.192 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2011 |
2011 |
HNRNPA1P2
|
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 2
|
|
2
|
1.000 |
0.115 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2011 |
2011 |
Entrez Id: |
100271700 |
Gene Symbol: |
NONOP2 |
NONOP2
|
|
non-POU domain containing, octamer-binding pseudogene 2
|
|
5
|
0.861 |
0.231 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2009 |
2009 |
Entrez Id: |
100286971 |
Gene Symbol: |
UBDP1 |
UBDP1
|
|
ubiquitin D pseudogene 1
|
|
2
|
1.000 |
0.115 |
|
0.100 |
None
|
1.000 |
1
|
1
|
2009 |
2009 |